BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29510423)

  • 1. Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.
    Clark EAS; Weiner SJ; Rouse DJ; Mercer BM; Reddy UM; Iams JD; Wapner RJ; Sorokin Y; Malone FD; O'Sullivan MJ; Peaceman AM; Hankins GDV; Dudley DJ; Caritis SN;
    Am J Perinatol; 2018 Aug; 35(10):1012-1022. PubMed ID: 29510423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
    Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
    BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-Specific Genetic Susceptibility to Adverse Neurodevelopmental Outcome in Offspring of Pregnancies at Risk of Early Preterm Delivery.
    Varner MW; Costantine MM; Jablonski KA; Rouse DJ; Mercer BM; Leveno KJ; Reddy UM; Buhimschi C; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; Carpenter M; O'sullivan MJ; Peaceman AM; Dudley DJ; Caritis SN;
    Am J Perinatol; 2020 Feb; 37(3):281-290. PubMed ID: 30731481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polymorphisms in neuroprotection and oxidative stress genes and neurodevelopmental outcomes after preterm birth.
    Costantine MM; Clark EA; Lai Y; Rouse DJ; Spong CY; Mercer BM; Sorokin Y; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; O'Sullivan MJ; Peaceman AM; Caritis SN
    Obstet Gynecol; 2012 Sep; 120(3):542-50. PubMed ID: 22914463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate.
    Cuff RD; Sullivan SA; Chang EY
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal Tobacco Exposure and Childhood Neurodevelopment among Infants Born Prematurely.
    Robbins LS; Blanchard CT; Sinkey RG; Harris SL; Tita AT; Harper LM
    Am J Perinatol; 2021 Feb; 38(3):218-223. PubMed ID: 32862421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes.
    McPherson JA; Rouse DJ; Grobman WA; Palatnik A; Stamilio DM
    Obstet Gynecol; 2014 Oct; 124(4):749-755. PubMed ID: 25198275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Predisposition to Adverse Neurodevelopmental Outcome of Extremely Low Birth Weight Infants.
    Varner MW; Thom EA; Cotten CM; Hintz SR; Page GP; Rouse DJ; Mercer BM; Costantine MM; Sorokin Y; Thorp JM; Ramin SM; Carpenter MW; O'Sullivan MJ; Peaceman AM; Saade GR; Dudley DJ; Caritis SN;
    Am J Perinatol; 2024 May; 41(S 01):e2710-e2716. PubMed ID: 37726016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
    Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
    PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal obesity and neuroprotective magnesium sulfate.
    McPherson J; Smiley S; Stamilio D
    Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Antenatal Corticosteroids and Magnesium Sulfate Therapy With Neurodevelopmental Outcome in Extremely Preterm Children.
    Gentle SJ; Carlo WA; Tan S; Gargano M; Ambalavanan N; Chawla S; Bell EF; Bann CM; Hintz SR; Heyne RJ; Tita A; Higgins RD;
    Obstet Gynecol; 2020 Jun; 135(6):1377-1386. PubMed ID: 32459430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants.
    Chollat C; Enser M; Houivet E; Provost D; Bénichou J; Marpeau L; Marret S
    J Pediatr; 2014 Aug; 165(2):398-400.e3. PubMed ID: 24837863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of cord serum cytokines with neurodevelopmental outcomes.
    Varner MW; Marshall NE; Rouse DJ; Jablonski KA; Leveno KJ; Reddy UM; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Malone FD; Carpenter M; O'Sullivan MJ; Peaceman AM; Hankins GD; Dudley DJ; Caritis SN;
    Am J Perinatol; 2015 Feb; 30(2):115-22. PubMed ID: 24936937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
    Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
    JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis.
    Wolf HT; Huusom LD; Henriksen TB; Hegaard HK; Brok J; Pinborg A
    BJOG; 2020 Sep; 127(10):1180-1188. PubMed ID: 32237069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
    Bachnas MA; Mose JC; Effendi JS; Andonotopo W
    J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnesium sulphate treatment decreases the risk of cerebral palsy after preterm birth].
    Wolf HT; Henriksen TB; Larsen ML; Pinborg A; Hegaard HK; Brok JS; Huusom LD
    Ugeskr Laeger; 2020 Nov; 182(47):. PubMed ID: 33215580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada.
    De Silva DA; Synnes AR; von Dadelszen P; Lee T; Bone JN; ; Magee LA
    Implement Sci; 2018 Jan; 13(1):8. PubMed ID: 29325592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring: The MAGENTA Randomized Clinical Trial.
    Crowther CA; Ashwood P; Middleton PF; McPhee A; Tran T; Harding JE;
    JAMA; 2023 Aug; 330(7):603-614. PubMed ID: 37581672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.